BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15925304)

  • 1. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome.
    Thurmon TF
    Nutrition; 2005 Jun; 21(6):774. PubMed ID: 15925304
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: case-control study.
    Czeizel AE; Puhó E
    Nutrition; 2005 Jun; 21(6):698-704; discussion 774. PubMed ID: 15925294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down's syndrome.
    Cavalli P; Bosi A; Bassi D
    Lancet; 2003 Jul; 362(9377):81. PubMed ID: 12853217
    [No Abstract]   [Full Text] [Related]  

  • 4. Can folic acid protect against congenital heart defects in Down syndrome?
    Meijer WM; Werler MM; Louik C; Hernandez-Diaz S; de Jong-van den Berg LT; Mitchell AA
    Birth Defects Res A Clin Mol Teratol; 2006 Oct; 76(10):714-7. PubMed ID: 17051586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Down's syndrome and neural-tube defects in the same family.
    Barkai G; Arbuzova S; Berkenstadt M; Heifetz S; Cuckle H
    Lancet; 2003 Apr; 361(9366):1331-5. PubMed ID: 12711468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: a report from the National Down Syndrome Project.
    Hollis ND; Allen EG; Oliver TR; Tinker SW; Druschel C; Hobbs CA; O'Leary LA; Romitti PA; Royle MH; Torfs CP; Freeman SB; Sherman SL; Bean LJ
    Am J Med Genet A; 2013 Mar; 161A(3):438-44. PubMed ID: 23401135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation.
    van Beynum IM; Kapusta L; den Heijer M; Vermeulen SH; Kouwenberg M; Daniëls O; Blom HJ
    Eur Heart J; 2006 Apr; 27(8):981-7. PubMed ID: 16524890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social and ethnic differences in folic acid use preconception and during early pregnancy in the UK: effect on maternal folate status.
    Brough L; Rees GA; Crawford MA; Dorman EK
    J Hum Nutr Diet; 2009 Apr; 22(2):100-7. PubMed ID: 19226351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate intakes and folate biomarker profiles of pregnant Japanese women in the first trimester.
    Mito N; Takimoto H; Umegaki K; Ishiwaki A; Kusama K; Fukuoka H; Ohta S; Abe S; Yamawaki M; Ishida H; Yoshiike N
    Eur J Clin Nutr; 2007 Jan; 61(1):83-90. PubMed ID: 16885932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down anomaly: new research aspects of an old and well known syndrome.
    Mikkelsen M
    Prog Clin Biol Res; 1985; 177():293-307. PubMed ID: 3160045
    [No Abstract]   [Full Text] [Related]  

  • 13. Down's syndrome--factors influencing its incidence.
    Ho LY
    Singapore Med J; 1989 Jun; 30(3):238-41. PubMed ID: 2531467
    [No Abstract]   [Full Text] [Related]  

  • 14. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels.
    Cowans NJ; Spencer K
    Prenat Diagn; 2005 Aug; 25(8):693-9. PubMed ID: 16050001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute respiratory infections during pregnancy and congenital abnormalities: a population-based case-control study.
    Acs N; Bánhidy F; Puhó EH; Czeizel AE
    Congenit Anom (Kyoto); 2006 Jun; 46(2):86-96. PubMed ID: 16732767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester combined screening for Down syndrome and other fetal anomalies.
    O'Leary P; Breheny N; Dickinson JE; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double aneuploidy (48,XXY,+21) of maternal origin in a child born to a 13-year-old mother: evaluation of the maternal folate metabolism.
    Biselli JM; Machado FB; Zampieri BL; Alves da Silva AF; Goloni-Bertollo EM; Haddad R; Eberlin MN; Vannucchi H; Carvalho VM; Medina-Acosta E; Pavarino-Bertelli EC
    Genet Couns; 2009; 20(3):225-34. PubMed ID: 19852428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean maternal age of Down's syndrome in Hyderabad, India.
    Rao VB
    J Indian Med Assoc; 1999 Jan; 97(1):25. PubMed ID: 10549185
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
    Morris JK; Wald NJ
    J Med Screen; 2007; 14(1):5-7. PubMed ID: 17362564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What you need to know about... Down's syndrome.
    Nurs Times; 2003 Jun 3-9; 99(22):28. PubMed ID: 12808746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.